Remyelination trial failures: Repercussions of ignoring neurorehabilitation and exercise in repair.
暂无分享,去创建一个
[1] J. Bansi,et al. Systematic Review of Exercise Studies in Persons with Multiple Sclerosis: Exploring the Quality of Interventions According to the Principles of Exercise Training , 2021, Neurology and Therapy.
[2] D. MacManus,et al. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study , 2021, The Lancet Neurology.
[3] A. Dufour,et al. Exercise rapidly alters proteomes in mice following spinal cord demyelination , 2021, Scientific Reports.
[4] N. Penner,et al. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers. , 2021, Multiple sclerosis and related disorders.
[5] D. Arnold,et al. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial , 2020, The Lancet Neurology.
[6] V. Yong,et al. Exercise and the brain in multiple sclerosis , 2020, Multiple sclerosis.
[7] E. Esposito,et al. Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases , 2020, Antioxidants.
[8] Charles Tator,et al. Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats , 2020, Neurobiology of Disease.
[9] G. Comi,et al. Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration , 2020, Frontiers in Immunology.
[10] V. Yong,et al. Exercise in multiple sclerosis and its models: Focus on the central nervous system outcomes , 2020, Journal of neuroscience research.
[11] B. Emery,et al. Axoglial interactions in myelin plasticity: Evaluating the relationship between neuronal activity and oligodendrocyte dynamics , 2019, Glia.
[12] M. Schwab,et al. Enhancing rehabilitation and functional recovery after brain and spinal cord trauma with electrical neuromodulation , 2019, Current opinion in neurology.
[13] S. Dietmann,et al. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells , 2019, Cell stem cell.
[14] D. Centonze,et al. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial , 2019, The Lancet Neurology.
[15] M. Conda-Sheridan,et al. A review of the molecular design and biological activities of RXR agonists , 2019, Medicinal research reviews.
[16] M. Ploughman,et al. Prolonged cortical silent period is related to poor fitness and fatigue, but not tumor necrosis factor, in Multiple Sclerosis , 2019, Clinical Neurophysiology.
[17] T. Yamashita,et al. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis , 2018, Cell Death & Disease.
[18] O. Kovalchuk,et al. Multimodal Enhancement of Remyelination by Exercise with a Pivotal Role for Oligodendroglial PGC1α. , 2018, Cell reports.
[19] J. Grutzendler,et al. Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain , 2018, Nature Neuroscience.
[20] S. Galetta,et al. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial , 2017, The Lancet Neurology.
[21] Gavin Giovannoni,et al. Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. , 2017, Multiple sclerosis and related disorders.
[22] D. Arnold,et al. Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study , 2016, Journal of Neurology.
[23] F. Sedel,et al. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis , 2016, Neuropharmacology.
[24] Geoffroy Saussez,et al. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery , 2016, Front. Hum. Neurosci..
[25] Bimal Lakhani,et al. Motor Skill Acquisition Promotes Human Brain Myelin Plasticity , 2016, Neural plasticity.
[26] Robin J. Vigouroux,et al. Uncoupling Neogenin association with lipid rafts promotes neuronal survival and functional recovery after stroke , 2015, Cell Death and Disease.
[27] D. Miller,et al. Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis. , 2014, Multiple sclerosis and related disorders.
[28] H. Praag,et al. Bridging animal and human models of exercise-induced brain plasticity , 2013, Trends in Cognitive Sciences.
[29] S. Mi,et al. Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic , 2013, CNS Drugs.
[30] B. Seitz,et al. A randomized, double‐blind, phase 2 study of erythropoietin in optic neuritis , 2012, Annals of neurology.
[31] David H. Miller,et al. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation , 2008, Magnetic resonance in medicine.
[32] J. Kleim,et al. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. , 2008, Journal of speech, language, and hearing research : JSLHR.
[33] Stephen J. Jones,et al. A serial MRI study following optic nerve mean area in acute optic neuritis. , 2004, Brain : a journal of neurology.
[34] Chao Zhao,et al. The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.
[35] J. Garthwaite,et al. Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. , 2014, Brain : a journal of neurology.
[36] P. Chambon,et al. Retinoid X receptor gamma signaling accelerates CNS remyelination , 2011, Nature Neuroscience.
[37] P. Rossini,et al. Cerebral restorative plasticity from normal ageing to brain diseases: a "never ending story". , 2010, Restorative neurology and neuroscience.